King of Prussia, PA, United States of America

Patrick Stoy

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • King of Prussia, PA (US) (2015 - 2016)
  • Collegeville, PA (US) (2021)

Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Patrick Stoy

Introduction

Patrick Stoy is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various medical conditions. With a total of 3 patents to his name, Stoy's work is recognized for its potential impact on healthcare.

Latest Patents

One of Stoy's latest patents is focused on a TRPV4 antagonist. This invention relates to a novel compound, specifically the compound 1-(((5S,7R)-3-(5-cyclopropylpyrazin-2-yl)-7-hydroxy-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl)methyl)-1H-benzo[d]imidazole-6-carbonitrile, along with its pharmaceutically acceptable salts and compositions. The compound is designed to treat a wide range of diseases, including atherosclerosis, edema, hypertension, inflammation, and various pulmonary disorders. Another patent involves spirocarbamate analogs, which are also used as TRPV4 antagonists, showcasing Stoy's innovative approach to addressing complex health issues.

Career Highlights

Throughout his career, Patrick Stoy has worked with prominent organizations, including GlaxoSmithKline Intellectual Property Limited and GlaxoSmithKline Intellectual Property (No. 2) Limited. His experience in these companies has allowed him to develop and refine his inventions, contributing to advancements in pharmaceutical research.

Collaborations

Stoy has collaborated with notable colleagues, including Carl A. Brooks and Guosen Ye. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Patrick Stoy's innovative work in the pharmaceutical field demonstrates his commitment to improving healthcare through targeted treatments. His contributions, particularly in the area of TRPV4 antagonists, highlight the importance of research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…